Skip to main content
. 2013 Apr 21;62(6):1123–1130. doi: 10.1007/s00262-013-1424-8

Fig. 1.

Fig. 1

Kaplan-–Meier plot of progression-free survival for patients with different CD8+CD28 subset status. The median progression-free survival (PFS) in patients with an increased CD8+CD28 subset percentage (≥24.0 %) was significantly lower than that in patients with a normal CD8+CD28 subset percentage (<24.0 %). (3.0 ± 0.3 vs. 5.0 ± 0.5 months, P < 0.001)